Test Price
2,800 AED✅ Home Collection Available
SNX14 Gene Cerebellar Ataxia NGS Test in Dubai, UAE – 2,800 AED
Executive Summary & Core Metrics
Accuracy Guarantee 99.9% Diagnostic Sensitivity via ISO‑Accredited NGS Processing.
Premium Logistics VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance Telephonic Post‑Test Clinical Guidance in result interpretation; immediate direct‑billing insurance verification via WhatsApp.
Insurance Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The SNX14 Gene Cerebellar Ataxia NGS Test detects pathogenic variants in the SNX14 gene causing autosomal recessive spinocerebellar ataxia type 20 (SCAR20). It utilizes high‑depth Next‑Generation Sequencing to deliver a definitive molecular diagnosis, enabling early intervention and accurate genetic counseling for affected families in the UAE.
| Feature | Our SNX14 NGS Test | Closest Alternative (Sanger Sequencing Only) |
|---|---|---|
| Methodology | NGS (comprehensive gene coverage, including deep intronic regions) | Sanger sequencing (exon‑by‑exon, limited scalability) |
| Sensitivity | >99.9% for SNV, indels, and CNV detection | ~95% for SNVs only; CNVs often missed |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Price (AED) | 2,800 | 2,000–2,500 (limited variant reporting) |
| Regulatory Compliance | ISO 9001:2015, UAE PDPL, Federal Law No. 2 of 2019 | Variable |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I emphasize that a positive SNX14 genetic result requires correlation with detailed neurological examination, family history, and neuroimaging. No single test replaces the art of clinical medicine. If you or your child experience progressive gait instability, dysarthria, or oculomotor abnormalities, this test can confirm the diagnosis but must be interpreted within a multidisciplinary team setting.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic test results do not replace ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
- This test is not for acute emergency diagnosis; it requires genetic counseling before sampling.
- Excluded if patient lacks capacity to consent and no legal guardian is available, per UAE PDPL and Federal Law No. 2 of 2019 for minors.
- If the patient presents with sudden loss of consciousness, acute stroke‑like symptoms, or severe unresponsive ataxia, proceed directly to the nearest ER — do not wait for genetic results.
- Individuals with a known hematological disorder affecting DNA quality must be assessed by the laboratory prior to sample collection.
Patient FAQ & Clinical Guidance
1. What does the SNX14 NGS test detect?
It identifies all major pathogenic variants in the SNX14 gene, including point mutations, small insertions/deletions, and copy number variants, providing clarity for autosomal recessive cerebellar ataxia type 20.
2. How should I prepare for the test?
You must attend a genetic counseling session to draw a detailed pedigree and review clinical history; no prolonged fasting is required, and the sample can be collected at home via our mobile phlebotomy team.
3. When will I receive the results?
Results are typically available within 3–4 weeks; comprehensive post‑test clinical guidance is provided to explain the findings and recommend next steps tailored to UAE care pathways.
UAE Regulatory & Data Privacy Adherence
This test fully complies with the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent processes adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is handled under strict confidentiality protocols within ISO 9001:2015 certified processes.
Clinical & Logistical Metadata
| Test Name | SNX14 Gene Cerebellar Ataxia NGS Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (3–5 mL in EDTA tube). VIP Mobile Phlebotomy available daily 8 AM–11 PM. |
| Methodology Used | Next-Generation Sequencing (NGS) – whole gene analysis including intronic regions |
| ICD-10-CM Code | G11.9 (Cerebellar ataxia, unspecified), G11.1 (Early-onset cerebellar ataxia) |
| LOINC Code | 81248-8 (Genetic testing for hereditary ataxia) |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians